164 related articles for article (PubMed ID: 23576466)
1. A novel therapeutic drug for colon cancer: EpCAM scFv-truncated protamine (tp)-siRNA.
Hao H; Zhen Y; Wang Z; Chen F; Xie X
Cell Biol Int; 2013 Aug; 37(8):860-4. PubMed ID: 23576466
[TBL] [Abstract][Full Text] [Related]
2. Expression of EpCAM and Wnt/ β-catenin in human colon cancer.
Zhou FQ; Qi YM; Xu H; Wang QY; Gao XS; Guo HG
Genet Mol Res; 2015 May; 14(2):4485-94. PubMed ID: 25966221
[TBL] [Abstract][Full Text] [Related]
3. An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer.
Liao MY; Lai JK; Kuo MY; Lu RM; Lin CW; Cheng PC; Liang KH; Wu HC
Oncotarget; 2015 Sep; 6(28):24947-68. PubMed ID: 26317650
[TBL] [Abstract][Full Text] [Related]
4. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
5. The role of nuclear EpICD in extrahepatic cholangiocarcinoma: association with β-catenin.
Jachin S; Bae JS; Sung JJ; Park HS; Jang KY; Chung MJ; Kim DG; Moon WS
Int J Oncol; 2014 Aug; 45(2):691-8. PubMed ID: 24888903
[TBL] [Abstract][Full Text] [Related]
6. [Effect of epithelial cell adhesion molecule on metastasis in hypopharyngeal carcinoma FaDu cells].
Mu YK; Yu L; Lu SM; Sa N; Wang HB; Xu W
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Dec; 48(12):1022-7. PubMed ID: 24507003
[TBL] [Abstract][Full Text] [Related]
7. EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.
Osta WA; Chen Y; Mikhitarian K; Mitas M; Salem M; Hannun YA; Cole DJ; Gillanders WE
Cancer Res; 2004 Aug; 64(16):5818-24. PubMed ID: 15313925
[TBL] [Abstract][Full Text] [Related]
8. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
Yamashita T; Budhu A; Forgues M; Wang XW
Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
[TBL] [Abstract][Full Text] [Related]
9. EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer.
Subramanian N; Kanwar JR; Kanwar RK; Sreemanthula J; Biswas J; Khetan V; Krishnakumar S
PLoS One; 2015; 10(7):e0132407. PubMed ID: 26176230
[TBL] [Abstract][Full Text] [Related]
10. The emerging role of EpCAM in cancer and stem cell signaling.
Munz M; Baeuerle PA; Gires O
Cancer Res; 2009 Jul; 69(14):5627-9. PubMed ID: 19584271
[TBL] [Abstract][Full Text] [Related]
11. Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis.
Warneke VS; Behrens HM; Haag J; Krüger S; Simon E; Mathiak M; Ebert MP; Röcken C
Br J Cancer; 2013 Oct; 109(8):2217-27. PubMed ID: 24008668
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific gene transfer via an adenoviral vector targeted to the pan-carcinoma antigen EpCAM.
Haisma HJ; Pinedo HM; Rijswijk A; der Meulen-Muileman I; Sosnowski BA; Ying W; Beusechem VW; Tillman BW; Gerritsen WR; Curiel DT
Gene Ther; 1999 Aug; 6(8):1469-74. PubMed ID: 10467371
[TBL] [Abstract][Full Text] [Related]
13. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.
Patriarca C; Macchi RM; Marschner AK; Mellstedt H
Cancer Treat Rev; 2012 Feb; 38(1):68-75. PubMed ID: 21576002
[TBL] [Abstract][Full Text] [Related]
14. Extracellular domain of EpCAM enhances tumor progression through EGFR signaling in colon cancer cells.
Liang KH; Tso HC; Hung SH; Kuan II; Lai JK; Ke FY; Chuang YT; Liu IJ; Wang YP; Chen RH; Wu HC
Cancer Lett; 2018 Oct; 433():165-175. PubMed ID: 29981429
[TBL] [Abstract][Full Text] [Related]
15. Nuclear EpICD expression and its role in hepatocellular carcinoma.
Park SY; Bae JS; Cha EJ; Chu HH; Sohn JS; Moon WS
Oncol Rep; 2016 Jul; 36(1):197-204. PubMed ID: 27176150
[TBL] [Abstract][Full Text] [Related]
16. Nuclear signalling by tumour-associated antigen EpCAM.
Maetzel D; Denzel S; Mack B; Canis M; Went P; Benk M; Kieu C; Papior P; Baeuerle PA; Munz M; Gires O
Nat Cell Biol; 2009 Feb; 11(2):162-71. PubMed ID: 19136966
[TBL] [Abstract][Full Text] [Related]
17. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
Terris B; Cavard C; Perret C
J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
[TBL] [Abstract][Full Text] [Related]
18. Construction, expression, and characterization of a recombinant immunotoxin targeting EpCAM.
Lv M; Qiu F; Li T; Sun Y; Zhang C; Zhu P; Qi X; Wan J; Yang K; Zhang K
Mediators Inflamm; 2015; 2015():460264. PubMed ID: 25960617
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic window of MuS110, a single-chain antibody construct bispecific for murine EpCAM and murine CD3.
Amann M; Brischwein K; Lutterbuese P; Parr L; Petersen L; Lorenczewski G; Krinner E; Bruckmeier S; Lippold S; Kischel R; Lutterbuese R; Kufer P; Baeuerle PA; Schlereth B
Cancer Res; 2008 Jan; 68(1):143-51. PubMed ID: 18172306
[TBL] [Abstract][Full Text] [Related]
20. Selective gene transfer into primary human gastric tumors using epithelial cell adhesion molecule-targeted adenoviral vectors with ablated native tropism.
Heideman DA; van Beusechem VW; Offerhaus GJ; Wickham TJ; Roelvink PW; Craanen ME; Pinedo HM; Meijer CJ; Gerritsen WR
Hum Gene Ther; 2002 Sep; 13(14):1677-85. PubMed ID: 12396621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
